To the Editor: This year marks 10 years of successful operation of the Sydney Medically Supervised Injecting Centre — Australia’s only supervised injecting facility (SIF). It is one of 90 such facilities globally, with SIFs operating in eight different countries for up to 25 years. Legislation to lift the trial status of the Sydney centre was passed in the lead-up to the recent New South Wales state election, nearly a decade after the centre opened. Despite not having explicitly supported the centre while in opposition, at the Centre’s 10-year anniversary event on 6 May 2011, the newly elected Liberal–National coalition government signalled its willingness to contribute to bipartisan support of the centre.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Marshall BDL, Milloy M-J, Wood E, et al. Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study. Lancet 2011; 377: 1429-1437.
- 2. Salmon AM, van Beek I, Amin J, et al. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction 2010; 105: 676-683.
- 3. Stoltz J, Wood E, Small W, et al. Changes in injecting practices associated with use of a medically supervised safer injection facility. J Public Health (Oxf) 2007; 29: 35-39.
- 4. Kimber J, Mattick RP, Kaldor JM, et al. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev 2008; 27: 602-612.e
- 5. Wood E, Kerr T, Small W, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ 2004; 171: 731-734.
- 6. Saha International. Economic evaluation of the medically supervised injecting centre at Kings Cross 2008. http://www.druginfo.nsw.gov.au/__data/page/1189/MSIC_Final_Report_26-9-08.pdf (accessed Jul 2011).
- 7. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey report. Drug statistics series no. 25. Canberra: AIHW, 2011. (AIHW Cat. No. PHE 145.)
Lisa Maher has received funding from the National Health and Medical Research Council and the National Institutes of Health.